Skip to main content
Caplight Logo









OxyNov Inc.

OxyNov Inc.

Private
CanadaHealthcare & Life Scienceshttps://www.oxynov.com/

Last Round

Grant

Feb 2, 2021

Total Funding Raised

$180,000

Company Overview

OxyNov Inc. is a medical device company that develops and commercializes automated oxygen therapy systems, including its flagship FreeO₂ device, to optimize respiratory care and improve patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

automated oxygen therapyoxygen titrationmedical deviceclosed-loop controlSpO2 monitoringrespiratory caresmart ventilatorintensive care technologyoxygen saturationdigital healthhealth IoTclinical automationpatient monitoringrespiratory therapymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OxyNov Inc. Comparables

Compare OxyNov Inc. with similar companies based on industry and business-model similarity.

OxyNov Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
O2matic ApS
89%
Masimo Corporation
78%
Vapotherm
76%

OxyNov Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 2, 2021
Series AOct 17, 2018
VC RoundMar 15, 2017

Key People

Founding team and executive leadership

Patrice Allibert

President and Chief Executive Officer

Executive Team

Marie-Josée Paré

CFO (part time), member of the Executive Commitee and the Strategic Commitee of the BoD

Executive Team

OxyNov Inc. Investors

Notable investors and investment history

OxyNov Inc. investors
InvestorRounds
Desjardins CapitalVC Round, Series A
Anges QuebecVC Round
Ville de QuébecGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2021

    $180K grant received from Ville de Québec

  • Oct 17, 2018

    Led by Vygon with participation from Desjardins Capital.

OxyNov Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OxyNov Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OxyNov Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCanada
Employee Range17
Year Founded2009
Last FundingFeb 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?